ImmunoGen, Inc. (IMGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
2.97-0.17 (-5.41%)
At close: 4:00 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close3.14
Bid0.00 x
Ask3.32 x 300
Day's Range2.91 - 3.19
52wk Range2.53 - 16.59
1y Target EstN/A
Market Cap258.62M
P/E Ratio (ttm)-1.80
Avg Vol (3m)2,081,487
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • TheStreet.com13 days ago

    7 Stocks Under $10 Making Big Up Moves

    Here's a technical look at how to trade several under-$10 stocks that were making big moves to the upside recently.

  • Business Wire16 days ago

    ImmunoGen Announces Departure of Chief Development Officer

    ImmunoGen, Inc. , a leader in the expanding field of antibody-drug conjugates for the treatment of cancer, today announced that Charles Morris, MBChB, MRCP, Executive Vice President and Chief Development Officer, is leaving the Company effective September 2 to pursue an opportunity closer to his primary residence in Pennsylvania.

  • ImmunoGen (IMGN) Reports Wider-than-Expected Loss in Q4
    Zacks20 days ago

    ImmunoGen (IMGN) Reports Wider-than-Expected Loss in Q4

    ImmunoGen (IMGN) reported a wider-than-expected loss of 51 cents per share in the fourth-quarter of fiscal 2016.